Fidelity International’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-113,625
Closed -$1.91M 934
2024
Q1
$1.91M Buy
113,625
+37,632
+50% +$571K ﹤0.01% 687
2023
Q4
$1.38M Buy
75,993
+4,452
+6% +$80.9K ﹤0.01% 689
2023
Q3
$1.21M Buy
71,541
+21,647
+43% +$310K ﹤0.01% 667
2023
Q2
$599K Sell
49,894
-16,368
-25% -$223K ﹤0.01% 709
2023
Q1
$863K Buy
66,262
+19,642
+42% +$322K ﹤0.01% 724
2022
Q4
$689K Buy
46,620
+10,580
+29% +$116K ﹤0.01% 728
2022
Q3
$319K Buy
+36,040
New +$454K ﹤0.01% 755
2022
Q2
Sell
-9,654
Closed -$183K 834
2022
Q1
$183K Sell
9,654
-9,557
-50% -$243K ﹤0.01% 792
2021
Q4
$674K Sell
19,211
-362,438
-95% -$11.8M ﹤0.01% 754
2021
Q3
$14M Sell
381,649
-101,406
-21% -$3.99M 0.02% 492
2021
Q2
$19M Buy
483,055
+137,068
+40% +$3.96M 0.02% 468
2021
Q1
$9.78M Buy
345,987
+72,230
+26% +$2.3M 0.01% 526
2020
Q4
$8.77M Buy
273,757
+5,719
+2% +$176K 0.01% 501
2020
Q3
$8.66M Buy
+268,038
New +$8.36M 0.01% 499

Other funds holding HCM

Fidelity International's HCM Position: Q2 2024 in Review

Fidelity International sold out of HUTCHMED (HCM) in Q2 2024, closing a stake of 113,625 shares — an estimated $1.91M sold.

Fidelity International first reported a position in HCM in Q3 2020 and held it in 14 quarters. The position peaked at $19M in Q2 2021. 67 funds tracked by Wall St. Rank hold HCM as of Q2 2024.

  • Fidelity International reported no remaining HUTCHMED position as of Q2 2024 after selling out during the quarter.
  • Fidelity International sold 113,625 HUTCHMED shares in Q2 2024, an estimated $1.91M.
  • Fidelity International first reported a position in HUTCHMED in Q3 2020 and held it in 14 quarters.
  • Fidelity International's HUTCHMED position peaked at $19M in Q2 2021.
  • 67 funds tracked by Wall St. Rank held HUTCHMED as of Q2 2024.

Based on Fidelity International's 13F filing for Q2 2024, filed 13 Aug 2024.